Ming-Ru Wu

NKG2D ligands as therapeutic targets.

Paul W. Spear, Ming-Ru Wu, Marie-Louise Sentman et al. · PubMed · 2013 · 219 citations · Full text

Life Sciences, Immunology, Oncology +13

Synthetic RNA-Based Immunomodulatory Gene Circuits for Cancer Immunotherapy

Lior Nissim, Ming-Ru Wu, Erez Pery et al. · Cell · 2017 · 178 citations · Full text

Life Sciences, Immunology, Oncology +14

An NKp30-Based Chimeric Antigen Receptor Promotes T Cell Effector Functions and Antitumor Efficacy In Vivo

Tong Zhang, Ming-Ru Wu, Charles L. Sentman · The Journal of Immunology · 2012 · 135 citations · Full text

Life Sciences, Immunology, Oncology +17

A high-throughput screening and computation platform for identifying synthetic promoters with enhanced cell-state specificity (SPECS)

Ming-Ru Wu, Lior Nissim, Doron Stupp et al. · Nature Communications · 2019 · 88 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +17

Diphosphothreonine-Specific Interaction between an SQ/TQ Cluster and an FHA Domain in the Rad53-Dun1 Kinase Cascade

Hyun Lee, Chunhua Yuan, Andrew Hammet et al. · Molecular Cell · 2008 · 81 citations · Full text

Life Sciences, Genetics, Molecular Biology +7